Vigil Neuroscience, Inc.
VIGL
$1.67
-$0.10-5.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.99% | 1.70% | 9.93% | 19.93% | 30.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.92% | 5.42% | 13.73% | 20.42% | 29.01% |
| Operating Income | -0.92% | -5.42% | -13.73% | -20.42% | -29.01% |
| Income Before Tax | -1.96% | -4.66% | -10.42% | -13.77% | -20.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.96% | -4.66% | -10.42% | -13.77% | -20.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.96% | -4.66% | -10.42% | -13.77% | -20.98% |
| EBIT | -0.92% | -5.42% | -13.73% | -20.42% | -29.01% |
| EBITDA | -0.86% | -5.26% | -13.47% | -20.02% | -28.57% |
| EPS Basic | 3.02% | -1.27% | -4.02% | 0.08% | 2.30% |
| Normalized Basic EPS | 3.02% | -1.27% | -4.03% | 0.08% | 2.28% |
| EPS Diluted | 3.02% | -1.27% | -4.02% | 0.08% | 2.30% |
| Normalized Diluted EPS | 3.02% | -1.27% | -4.03% | 0.08% | 2.28% |
| Average Basic Shares Outstanding | 5.05% | 3.46% | 6.10% | 12.77% | 22.32% |
| Average Diluted Shares Outstanding | 5.05% | 3.46% | 6.10% | 12.77% | 22.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
